Erythroid hypoplasia

Erythroid hypoplasia: Description, Causes and Risk Factors:Erythroid hypoplasia is a condition in which an abnormally low number of red blood cells are produced and released into the body. There are a number of different conditions that can cause this disorder, some of them congenital and some of them caused by disease or injury. Patients with this condition may have moderate-to-severe anemia and can be at risk from lack of oxygen in the blood and cells. Blood transfusions are often used to treat this disorder in an emergency. In some patients, erythroid hypoplasia may need to be treated long term through the use of blood transfusions while in other cases the disorder may correct on its own or with the assistance of medication.Erythroid hypoplasia is a rare disorder characterized by a profound reduction in erythroblasts in the bone marrow. It can be a congenital disorder or can be acquired in association with an underlying disease. In the acquired group, the most common disease associations are with thymoma, viral infections, connective tissue diseases, and malignancy. Occasional reports have documented the occurrence of erythroid hypoplasia in patients with myelodysplastic syndrome (MDS). These patients present with severe anemia, reticulocytopenia, and a paucity of recognizable erythroid cells in the bone marrow, associated with some evidence of an intrinsic cell defect. In addition to erythroid hypoplasia, bilineage or trilineage dysplasia in a high percentage of cells (> 20%) is a crucial determinant for the recognition of this entity.The exact prevalence of erythroid hypoplasia in MDS is not known. In a series of 360 cases of MDS diagnosed in a single institute over a 10 year period, six (prevalence of 1.6%) were found to have MDS with erythroid hypoplasia/aplasia. In a review of the literature only 16 well documented cases of MDS with erythroid hypoplasia/aplasia. In that review, there was a male predominance (male to female ratio of 3:1), with a mean age of 70 years (range, 41-87). There were no pediatric cases in their series.A 54-year-old woman was admitted due to high-grade fever, cervical lymphadenopathy and general malaise. On examination, severe anemia was noted, direct Coombs and cold hemagglutinin tests were positive and the haptoglobin level was low in the peripheral blood. However, a bone marrow examination revealed marked erythroid hypoplasia. A diagnosis was made of co-existing combined type autoimmune hemolytic anemia (AIHA) and erythroid hypoplasia. A pathologic diagnosis of de novo CD5-positive diffuse large B-cell lymphoma (de novo CD5'+' DLBCL) was made based on a cervical lymph node biopsy. The patient was treated with CHOP accompanied by rituximab (R-CHOP), resulting in complete remission after 3 courses of chemotherapy. The AIHA and erythroid hypoplasia subsided after 2 courses of R-CHOP. The sera obtained during erythroid hypoplasia significantly inhibited the growth of erythroid progenitor cells (erythroid colony-forming units, CFU-E) from her bone marrow collected after recovery.Symptoms:erythroid hypoplasiaThe symptoms of erythroid hypoplasia are the same as those experienced with other types of anemia. Unexplained fatigue is the most common symptom because the decrease in oxygen in the blood makes it difficult for the body and brain to receive enough oxygen. Feelings of being out of breath are also commonly experienced with erythroid hypoplasia as are feelings of dizziness or faintness. Patients with low red blood cell counts may also appear pale.Diagnosis:The first step in the diagnosis of erythroid hypoplasia is detection with reliable, accurate tests so that important clues to underlying disease are not overlooked and patients are not subjected to unnecessary tests for and treatment.Tests:CBC.
  • Bone marrow examination.
Treatment:Patients with severe erythroid hypoplasia may require emergency medical attention. A severe drop in the number of red blood cells in a patient's bloodstream may cause the patient to lose consciousness and suffer brain damage. An emergency transfusion can provide relief from the symptoms of severe anemia. In some cases, however, patients may have sustained irreversible damage to the hematopoietic stem cells, in which case blood or marrow treatments may be needed frequently in order to keep the patient from showing symptoms of erythroid hypoplasia. In other cases, medication that stimulates red blood cell production may be enough to correct the disorder.NOTE: The above information is educational purpose. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition.DISCLAIMER: This information should not substitute for seeking responsible, professional medical care.

2 Comments

  1. Himangshu Barman

    Respected Sir/Madam
    I am sending some findings of a patient who is my relative.
    BONE MARROW ASPIRATION REPORTING:
    M:E ratio 1:1
    Erythroid: Erythropoiesis-Normoblastic maturation, mild erythroid hyperplasia
    BONE MARROW BIOPSY REPORTING:
    Normocellular bone marrow with trilineage haematopoeisis. Erythroid hyperplasia noted with megaloblastic maturation.
    Megakarocyte are seen.
    Subtle diffuse intersistial increase in atypical cells with distinct cell membrane and abundant clear cytoplasm noted.

    Please in form me whether the patient is curaeable for he may develop leukomea in near future. Patient is maale in sex with 42 years and his father died 2 years ago in leukomea

    Reply
    • maisteri

      It is not possible to predict whether a person will develop leukaemia or not at some point in the future. So far there are no signs of malignancy. Atypical cells may be present in a healthy person, this doesn’t mean that a person will develop blood cancer. Although megaloblasts are suggestive of B12-deficiency and pernicious anaemia which is curable.

      Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Cart Preview

Ketogenic Diet May Be Actually Harmful to Your Health

Ketogenic Diet May Be Actually Harmful to Your Health

Recent research, performed by Sara Seidelman, a cardiologist and nutrition researcher from Brigham and Women’s Hospital in Boston, USA, finds that diets which ban entire food groups from the eating plan, for example, ketogenic diet, may actually harm your health. The...

Regular Bedtime Linked to Better Heart Health and Metabolism

Regular Bedtime Linked to Better Heart Health and Metabolism

According to a recent study, completed by the scientists from the Duke University Medical Center in Durham, USA, regular bedtime is important for heart health and metabolism. A team of scientists examined the sleeping patterns of approximately 2,000 adults aged...

[WpProQuiz 1]

Featured Products

The 5 Best Accessories for Sports Fans

It is very entertaining to be a sport fan. There is a big variety of sport games that are extremely interesting to follow. Moreover, it is always fun to anticipate the score and watch the enthusiasm live. One of the benefits of being sports fan is using different...

read more

Exercise May Serve as an Antidepressant

A new study of nearly 18,000 participants found that those with high fitness at middle age were significantly less likely to die from heart disease in later life, even if they were diagnosed with depression. Doctor's Tips: How to Stay Fit While Treating Depression Dr....

read more

Fitness: Warm Ups Can Chill Out the Perfomance

The warm ups are supposed to increase body temperature and blood flow so the muscles and surrounding joints become more responsive and prepared for physical activity. Although there’s a neurological element to warm-ups, most research focuses on the physiological...

read more